Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M45,540Revenue $M101,889Net Margin (%)2.2Altman Z-Score3.1
Enterprise Value $M60,797EPS $3.2Operating Margin %4.0Piotroski F-Score8
P/E(ttm)20.8Beneish M-Score-2.6Pre-tax Margin (%)3.5Higher ROA y-yY
Price/Book2.810-y EBITDA Growth Rate %24.4Quick Ratio0.5Cash flow > EarningsY
Price/Sales0.55-y EBITDA Growth Rate %20.7Current Ratio0.6Lower Leverage y-yN
Price/Free Cash Flow10.7y-y EBITDA Growth Rate %20.6ROA % (ttm)4.3Higher Current Ratio y-yY
Dividend Yield %--PEG1.0ROE % (ttm)12.3Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M676ROIC % (ttm)8.1Gross Margin Increase y-yY

Gurus Latest Trades with ESRX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ESRXChris Davis 2015-12-31 Reduce-1.22%$81.3 - $89.14
($85.77)
$ 67.34-21%Reduce -39.64%5,531,779
ESRXRobert Olstein 2015-12-31 Buy 0.55%$81.3 - $89.14
($85.77)
$ 67.34-21%New holding49,000
ESRXDodge & Cox 2015-12-31 Reduce-0.23%$81.3 - $89.14
($85.77)
$ 67.34-21%Reduce -10.16%25,520,318
ESRXCharles Brandes 2015-12-31 Reduce-0.09%$81.3 - $89.14
($85.77)
$ 67.34-21%Reduce -3.53%2,041,802
ESRXJohn Keeley 2015-12-31 Reduce-0.03%$81.3 - $89.14
($85.77)
$ 67.34-21%Reduce -43.39%15,820
ESRXKen Fisher 2015-12-31 Add$81.3 - $89.14
($85.73)
$ 67.34-21%Add 1.06%464,733
ESRXMario Gabelli 2015-12-31 Reduce$81.3 - $89.14
($85.77)
$ 67.34-21%Reduce -1.48%115,034
ESRXGlenn Greenberg 2015-09-30 Sold Out -4.47%$80 - $94.08
($87.1)
$ 67.34-23%Sold Out0
ESRXChris Davis 2015-09-30 Reduce-1.19%$80 - $94.08
($87.1)
$ 67.34-23%Reduce -29.44%9,164,920
ESRXWallace Weitz 2015-09-30 Reduce-0.15%$80 - $94.08
($87.1)
$ 67.34-23%Reduce -5.45%1,066,089
ESRXJoel Greenblatt 2015-09-30 Add0.07%$80 - $94.08
($87.1)
$ 67.34-23%Add 136.07%146,565
ESRXCharles Brandes 2015-09-30 Reduce-0.05%$80 - $94.08
($87.1)
$ 67.34-23%Reduce -1.94%2,116,586
ESRXDodge & Cox 2015-09-30 Add0.04%$80 - $94.08
($87.1)
$ 67.34-23%Add 1.69%28,405,375
ESRXHOTCHKIS & WILEY 2015-09-30 Reduce-0.04%$80 - $94.08
($87.1)
$ 67.34-23%Reduce -6.91%1,762,200
ESRXVanguard Health Care Fund 2015-09-30 Sold Out -0.03%$80 - $94.08
($87.1)
$ 67.34-23%Sold Out0
ESRXKen Fisher 2015-09-30 Reduce-0.01%$80 - $94.08
($87.1)
$ 67.34-23%Reduce -13.80%459,838
ESRXMario Gabelli 2015-09-30 Reduce$80 - $94.08
($87.1)
$ 67.34-23%Reduce -1.77%116,759
ESRXGlenn Greenberg 2015-06-30 Reduce-4.65%$83.85 - $91.18
($87.35)
$ 67.34-23%Reduce -50.24%1,739,482
ESRXWallace Weitz 2015-06-30 Reduce-0.71%$83.85 - $91.18
($87.35)
$ 67.34-23%Reduce -21.14%1,127,519
ESRXVanguard Health Care Fund 2015-06-30 Reduce-0.56%$83.85 - $91.18
($87.35)
$ 67.34-23%Reduce -95.26%151,900
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ESRX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


ESRX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Wimberly GarySr. VP & Ch. Information Off. 2015-06-09Sell1,644$87.14-22.72view
Wimberly GarySr. VP & Ch. Information Off. 2015-06-01Sell46,069$86.15-21.83view
STERNBERG SEYMOURDirector 2015-05-27Sell6,870$90.23-25.37view
MYERS WOODROW A JRDirector 2015-05-08Sell14,342$85.32-21.07view
BENANAV GARY GDirector 2015-05-04Sell10,000$87.39-22.94view
Wade Sara ESr. VP, Ch. Human Res. Off. 2015-05-01Sell12,000$86.53-22.18view
Norton David ASVP, Specialty & Supply Chain 2015-05-01Sell12,029$86.53-22.18view
Stettin Glen D.Sr. VP, Clin. Res. & New Sol. 2015-03-02Sell2,674$84.39-20.2view
Stettin Glen D.Sr. VP, Clin. Res. & New Sol. 2015-02-25Sell27,603$87.55-23.08view
Ebling Keith J.Exec. VP and General Counsel 2014-12-02Sell10,000$84.25-20.07view

Quarterly/Annual Reports about ESRX:

    News about ESRX:

    Articles On GuruFocus.com
    First Pacific Advisors Slashes Stake in CVS Health Dec 17 2015 
    Health Care Stocks Play Prominent Roles in Steven Romick's Transactions Dec 15 2015 
    Glenn Greenberg Sells Stake in Express Scripts Holding Dec 03 2015 
    Dodge & Cox Comments on Express Scripts Nov 19 2015 
    Jeremy Grantham Adds to Stakes in Pharmaceutical Stocks Nov 18 2015 
    Steven Romick Sells CVS, Buys United Technologies Oct 27 2015 
    Companies Return 12-Month Record Amount to Shareholders Sep 25 2015 
    Dodge & Cox Funds' 2015 Equity Mid-Year Review Aug 19 2015 
    Jeremy Grantham Reduces More Than 250 Stakes in Second Quarter Aug 18 2015 
    Will Bill Ackman Go After Express Scripts Next? Jun 30 2015 

    More From Other Websites
    Express Scripts Giving 'Extra Scrutiny' to Valeant Prescriptions Feb 12 2016
    Express Scripts sees slow 2016 sales for new cholesterol drugs Feb 12 2016
    Anthem Expects to Generate Substantial Savings from Pharmaceutical Pricing in 2016 Feb 08 2016
    Express Scripts Holding Company Announces Fourth Quarter and Full Year 2015 Earnings Conference Call Feb 04 2016
    Technical Snapshot on Health Care Plans Stocks -- Express Scripts Holding, CVS Health, UnitedHealth... Feb 02 2016
    Costs to treat common ailments a prescription for pain Feb 01 2016
    Express Scripts drops coverage of Valeant diabetes drug Glumetza Jan 29 2016
    One of the biggest healthcare companies in America fired a warning shot at Valeant Jan 29 2016
    Payers see price leverage with entry of Merck hepatitis C drug Jan 29 2016
    Express Scripts Calls Out Valeant, Says It's 'Holding Pharmaceutical Manufacturers Accountable For... Jan 29 2016
    Express Scripts Blocks Valeant Diabetes Drug in Cost Fight Jan 29 2016
    The Health Care Delusion Hillary And Trump Share Jan 27 2016
    Express Scripts Shares Briefly Hit By Hillary Clinton Tweet Jan 25 2016
    Biotech dips on another Hillary Clinton drug price tweet Jan 25 2016
    Leerink: Still Cautious On Express Scripts, CVS Looks Well Positioned Jan 22 2016
    Express Scripts downgraded by Morgan Stanley Jan 21 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    Srichardson
    ReplySrichardson - 1 year ago
    How do you see the % of Total Asset for a position in a guru portfolio?
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK